IFNG and cancer: Three IFN-γ signatures tend to be enriched in the PDL2-high group among cancers (Figures 1(g)–1(i)): DLBC, LUSC, COAD, SARC, and TGCT were the leading cancers with the highest NES by the Louis signature analysis (Figure 1(j)).